StreetAlpha
Xilio Therapeutics, Inc. · 13F filings

XLO Institutional Ownership

Holdings as of Sep 30, 2026From SEC Form 13FUpdated

Who owns Xilio Therapeutics, Inc. and what the big funds did with it last quarter, from every SEC 13F filing. 30 funds reported holding XLO at Sep 30, 2026, together owning 53.5% of the company.

← XLO stock page

Who owns the most XLO

% of company · value · change
  1. 1Bain Capital Life Sciences Investors, LLC9.40%$6M0
  2. 2Gilead Sciences, Inc.9.21%$5.9M0
  3. 3Orbimed Advisors LLC8.38%$5.4M0
  4. 4Adage Capital Partners Gp, L.l.c.6.58%$4.2M+353K
  5. 5Frazier Life Sciences Management, L.P.5.98%$3.8M0
The top 5 own 39.5% of XLO. Biggest move: Adage Capital Partners Gp, L.l.c. bought 353K shares (+$3.2M).See all top holders ↓
Free account: all 25 XLO holders, every new XLO 13F filing as it lands, and each fund’s full portfolio. Create free accountSign in
AI Pro · stock alerts

Get an alert when the big funds move XLO

13F season runs for 45 days after each quarter. We watch every filing and tell you the moment a superinvestor or one of XLO’s top 25 holders buys, sells or exits (moves of 5% or more), by email or on your phone.

Stock alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

What an alert looks like
Stonepine Capital Management cut XLO by 37K sharesQ3 2026 13F · −$334K
Adage Capital Partners Gp, L.l.c. added to XLO by 353K sharesQ3 2026 13F · +$3.2M
Real XLO moves from last quarter’s filings. Alerts come from public SEC 13F filings and are not investment advice.
Fund sentiment
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲16 buying vs 7 selling
  • ▲Held by funds +5.3 pts
  • ▲Funds holding +4
  • ▼Superinvestors: 0 added, 2 cut
  • ●Put/call not meaningful

What the filings show, not a forecast. Positions can be up to 45 days old and leave out short sales.

Funds holding30+4 vs Q2 2026
Held by funds53.5%+5.3 pts
Value held$34.2M3.8M shares
Put/call ratio–market makers left out

Funds holding and ownership

8 quarters
Q4 2024: 35 fundsQ4 '24Q1 2025: 35 fundsQ1 '25Q2 2025: 35 fundsQ2 '25Q3 2025: 36 fundsQ3 '25Q4 2025: 37 fundsQ4 '25Q1 2026: 24 fundsQ1 '26Q2 2026: 26 fundsQ2 '26Q3 2026: 30 fundsQ3 '2653.5% owned
Funds holdingHeld by funds %

Quarter over quarter

all 13F filers
Q3 2026This quarterQ2 2026Change
Funds holding3026+15.4%
In funds' top 10110.0%
13F shares3.8M3.4M+10.9%
Held by funds53.5%48.2%+5.3 pts
New positions710−30.0%
Increased94+125.0%
Reduced440.0%
Sold out37−57.1%
Calls (shares)00–
Puts (shares)00–
Put/call ratio–––

Buyers vs sellers

adding or new vs cutting or sold out
Q1 2025: 14 buyingQ1 2025: 13 sellingQ1 '25Q2 2025: 9 buyingQ2 2025: 16 sellingQ2 '25Q3 2025: 10 buyingQ3 2025: 7 sellingQ3 '25Q4 2025: 15 buyingQ4 2025: 14 sellingQ4 '25Q1 2026: 20 buyingQ1 2026: 36 sellingQ1 '26Q2 2026: 14 buyingQ2 2026: 11 sellingQ2 '26Q3 2026: 16 buyingQ3 2026: 7 sellingQ3 '26
Buying 16Selling 7latest quarter

Superinvestors in XLO

All superinvestors →

Who owns XLO

share of fund held shares
  • Index and passive funds8.1%
  • Active managers and hedge funds90.4%
  • Banks and brokers1.4%
  • Pensions, insurers and other0.0%

The top 10 holders own 92.7% of all XLO shares that funds reported. Groups are our own grouping of filers by name.

Top holders

Q3 2026
#FundOf companySharesValueChange
1Bain Capital Life Sciences Investors, LLC9.40%664K$6M0
2Gilead Sciences, Inc.9.21%650K$5.9M0
3Orbimed Advisors LLC8.38%592K$5.4M0
4Adage Capital Partners Gp, L.l.c.6.58%465K$4.2M+353K
5Frazier Life Sciences Management, L.P.5.98%423K$3.8M0
6Vanguard Capital Management LLC2.81%198K$1.8M+20K
7Stonepine Capital Management, LLC2.68%189K$1.7M−37K
8Sio Capital Management, LLC2.16%152K$1.4M0
9Merck & Co., Inc.1.50%106K$959K0
10Renaissance Technologies LLC0.90%64K$575K−600
🔒 15 more top holders. Create a free account or sign in to see them.

XLO institutional ownership FAQ

Who owns the most XLO stock?

In Q3 2026 13F filings the largest holder of XLO was Bain Capital Life Sciences Investors, LLC, followed by Gilead Sciences, Inc. and Orbimed Advisors LLC. Index fund managers are usually the biggest holders of large companies.

What percentage of XLO is owned by institutions?

Funds that file 13F reports held 53.5% of XLO's shares at Sep 30, 2026, compared with 48.2% a quarter earlier. That counts every manager with more than $100 million in US stocks.

Are hedge funds buying XLO?

In Q3 2026, 16 funds bought XLO (7 of them new positions) and 7 sold (3 sold out completely). Among well known investors, 0 added and 2 cut. Our fund sentiment for XLO is bullish.

What is XLO's institutional put/call ratio?

Too few option positions were reported for a meaningful ratio.

How current is this XLO ownership data?

13F filings show holdings at the end of each quarter and are due within 45 days, so positions can be up to six weeks old when they appear. We add each new filing within minutes, and the "filed so far" list shows funds that have already reported the next quarter.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Fund sentiment summarises what 13F filings show and is not a forecast. Holdings come from SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.